Non-surgical methods of pain treatment improving the quality of life of patients with endometriosis
DOI:
https://doi.org/10.12775/JEHS.2022.12.12.037Keywords
endometriosis, hormonal treatment, pain treatmentAbstract
Introduction : Endometriosis is a disease that currently affects 10-15% of women of reproductive age worldwide. The main problem of female patients, in addition to infertility, is pain, which varies greatly, significantly reduces the quality of life and affects family, social, sexual and professional life. Pharmacological treatment, which is applied both after the excision of the lesions and in patients who were not eligible for surgery, is an important element of pain therapy. There are also other methods, such as appropriate diet change, supplementation, acupuncture, electrotherapy, which are partially effective.
Method : review of the recent literature based on PubMEd ,Google scholar research based on the following keywords : endometriosis treatment, hormonal treatment of endometriosis, quality of life of patients with endometriosis
Purpose of work : Comparison of the mode of action and effectiveness of individual non-surgical methods of treating pain in patients with endometriosis.
References
Ahn, S.H.; Singh, V.; Tayade, C. Biomarkers in endometriosis: Challenges and opportunities.Fertil. Steril.2017,107, 523–532
Ribeiro De Carvalho França P, Carolina A, Lontra P, Fernandes PD. molecules Endometriosis: A Disease with Few Direct Treatment Options. 2022; Available from: https://doi.org/10.3390/molecules27134034
Smolarz B, Szyłło K, Romanowicz H. Molecular Sciences Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). 2021; Available from: https://doi.org/10.3390/ijms221910554
Rossi V, Tripodi F, Simonelli C, Galizia R, Nimbi FM. Endometriosis-associated pain: a review of quality of life, sexual health and couple relationship. Minerva Obstet Gynecol. 2021 Oct;73(5):536-552. doi: 10.23736/S2724-606X.21.04781-3. Epub 2021 Apr 27. PMID: 33904688.
Farshi, N.; Hasanpour, S.; Mirghafourvand, M.; Esmaeilpour, K. Effect of Self-Care Counselling on Depression and Anxiety inWomen With Endometriosis: A Randomized Controlled Trial.BMC Psychiatry2020,20, 391
Burney, R.O. Biomarker development in endometriosis.Scand. J. Clin. Lab. Investig. Suppl.2014,244, 75–81. [CrossRef] [PubMed]
Asghari, S.; Valizadeh, A.; Aghebati-Maleki, L.; Nouri, M.; Yousefi, M. Endometriosis: Perspective, lights, and shadows ofetiology.Biomed. Pharm.2018,106, 163–174. [CrossRef]
Berlanda N., Vercellini P., Fedele L.: The outcomes of repeat surgery for recurrent symptomatic endometriosis. Curr. Opin. Obstet. Gynecol., 2010; 22: 320–325.
Louise Jones G, Török P, Morotti M, Barbara G, Buggio L, Facchin F, et al. Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence. 2021; Available from: www.frontiersin.org
Vercellini P, Eskenazi B, Consonni D, et al. Oral contraceptives and risk of endometriosis: A systematic review and meta-analysis. Hum Reprod Update. 2011. https://doi.org/10.1093/humupd/dmq042.
Meresman GF, Augé L, Barañao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril. 2002;77(6):1141–7. https://doi.org/10.1016/s0015-0282(02)03099-6.
Wu L, Wu Q, Liu L. Oral contraceptive pills for endometrio-sis after conservative surgery: a systematic review and meta-analysis. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2013;29(10):883–90. https://doi.org/10.3109/09513590.2013.819085
Hee L., Kettner L.O., Vejtorp M.: Continuous use of oral contraceptives: an overview of effects and side-effects. Acta Obstet. Gynecol. Scand., 2013; 92: 125–136.
Dunselman GAJ, Vermeulen N, Becker C, et al. ESHRE guide-line: Management of women with endometriosis. Hum Reprod. 2014. https://doi.org/10.1093/humrep/det457
Barra F, Scala C, Ferrero S. Current understanding on pharma-cokinetics, clinical efficacy and safety of progestins for treat-ing pain associated to endometriosis. Expert Opin Drug Metab Toxicol. 2018;14(4):399–415. https://doi.org/10.1080/17425255.2018.1461840.
1. Vannuccini S, Clemenza S, Rossi M, Petraglia F. Hormonal treatments for endometriosis: The endocrine background. Rev Endocr Metab Disord [Internet]. 1:3. Available from: https://doi.org/10.1007/s11154-021-09666-w
Levine D, Kaufman L, Cuenca VG, Badawy SZA. Cell growth effects of leuprolide on cultured endometrioma cells. J Reprod Med. 2007;52(7):581–4 (PMID: 17847754).
Simoens S., Dunselman G., Dirksen C. i wsp: The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum. Reprod., 2012; 27: 1292–1299.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Jagna Golemo, Anna Gryc, Aleksandra Nowińska, Monika Grudzień, Rafał Świdziński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 613
Number of citations: 0
